Foreign Facilities Get Details From US FDA On Avoiding ‘Refusal To Allow Inspection’ Violation
Executive Summary
Guidance states regulatory violation of refusing to permit entry of FDA investigator to inspect or not permitting an inspection includes “statements, actions, and passive behaviors that prevent or delay us from scheduling or fully conducting an inspection.”
You may also be interested in...
US FDA Takes A Scientific Look At Hot-Button Issue Of Unannounced Foreign Inspections
As Congress beats the drums for surprise inspections abroad, the agency plans a statistically rigorous comparison of announced versus unannounced inspections. Meanwhile, as authorities shed COVID-19 precautions, FDA investigators flood back into the field domestically, with surge of foreign inspections to follow soon.
FSMA Supplier Verification Rule Affects Finished Supplement Importers
Proposed FSMA rules would subject imported food products, including supplements, to the same safety standards as domestically produced food. The proposals are reminders that although supplement manufacturing is exempt from FSMA provisions redundant to GMP requirements, the act adds regulatory burdens for some firms.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.